MediPharm Labs (TSE:LABS) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
MediPharm Labs reported a significant improvement in its financial results for the third quarter, with net revenue rising by 15% and gross profit improving by 29% compared to the previous year. The company has also paid off all its convertible debt, allowing it to focus on expanding in international markets, particularly Germany and Australia, where it has seen substantial growth.
For further insights into TSE:LABS stock, check out TipRanks’ Stock Analysis page.
